Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Cns Pharmaceuticals Inc
(NQ:
CNSP
)
0.1325
-0.0085 (-6.03%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 16, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Cns Pharmaceuticals Inc
< Previous
1
2
3
4
5
6
7
8
9
10
11
Next >
BioMedNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Publishes Q2 2024 Results
August 15, 2024
Via
Investor Brand Network
Exposures
Product Safety
CNS Pharmaceuticals Reports Second Quarter 2024 Financial Results
August 15, 2024
Via
ACCESSWIRE
Study Uncovers How Brain Tumors Evolve During Treatment
August 05, 2024
Via
Investor Brand Network
BioMedNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Inks Exclusive License in ‘Transformational’ Step to Treating GBM
July 30, 2024
Via
Investor Brand Network
Topics
Intellectual Property
Exposures
Intellectual Property
CNS Pharmaceuticals Expands Pipeline with In-License of Late Stage, Novel Potential Blood Brain Barrier Permeable Abeotaxane for Treatment of Brain Malignancies
July 30, 2024
Via
ACCESSWIRE
CNS Pharmaceuticals to Participate in the Virtual Investor Closing Bell Series
July 16, 2024
Via
ACCESSWIRE
Brain Cancer in Kids Could Soon Be Detected by 10-Minute Scan
June 21, 2024
Via
Investor Brand Network
CNS Pharmaceuticals to Present at Alliance Global Partner's 2024 Healthcare Company Showcase
May 20, 2024
Via
ACCESSWIRE
CNS Pharmaceuticals to Present at the LSX World Congress 2024
April 23, 2024
Via
ACCESSWIRE
BioMedNewsBreaks — CNS Pharmaceuticals Inc. (NASDAQ: CNSP) CMO to Present Poster at Upcoming SNO/ASCO CNS Cancer Conference
July 25, 2024
Via
Investor Brand Network
CNS Pharmaceuticals Announces Acceptance of Abstract for Poster Presentation at the 2024 SNO/ASCO CNS Cancer Conference
July 25, 2024
Via
ACCESSWIRE
Study Uncovers Ancient Egyptian Attempts to Surgically Remove Brain Cancer
July 22, 2024
Via
Investor Brand Network
BioMedNewsBreaks — CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Exec to Present at Upcoming Virtual Investor Closing Bell Series
July 16, 2024
Via
Investor Brand Network
Research Identifies How Glioblastoma Develops Resistance to Immunotherapy
July 08, 2024
Via
Investor Brand Network
BioMedNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Enters Securities Purchase Agreements Worth Estimated $1.98M
July 05, 2024
Via
Investor Brand Network
CNS Pharmaceuticals Announces Pricing of Registered Direct Offering and Concurrent Private Placement
July 03, 2024
Via
ACCESSWIRE
TinyGemsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Announces Pricing of Registered Direct, Concurrent Private Placement
June 26, 2024
Via
Investor Brand Network
CNS Pharmaceuticals Announces Pricing of Registered Direct Offering and Concurrent Private Placement
June 26, 2024
Via
ACCESSWIRE
BioMedNewsBreaks — CNS Pharmaceuticals Inc.(NASDAQ: CNSP) Enters in Purchase Agreements, Announces Pricing
June 17, 2024
Via
Investor Brand Network
CNS Pharmaceuticals Announces Pricing of Registered Direct Offering and Concurrent Private Placement
June 14, 2024
Via
ACCESSWIRE
BioMedNewsBreaks — CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Announces Reverse Stock Split
June 03, 2024
Via
Investor Brand Network
Virginia Tech Clinical Trial Seeks End to Brain Cancer Surgery
June 03, 2024
Via
Investor Brand Network
CNS Pharmaceuticals Announces Reverse Stock Split
June 03, 2024
Via
ACCESSWIRE
BioMedNewsBreaks — CNS Pharmaceuticals Inc. (NASDAQ: CNSP) CEO to Present at 2024 Healthcare Company Showcase
May 20, 2024
Via
Investor Brand Network
BioMedNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Releases Q1 2024 Financial, Business Report
May 16, 2024
Via
Investor Brand Network
CNS Pharmaceuticals Reports First Quarter 2024 Financial Results
May 16, 2024
Via
ACCESSWIRE
New mRNA Vaccine Offers Hope Against Glioblastoma
May 15, 2024
Via
Investor Brand Network
Researchers Seek to Develop Genetically Engineered Brain Cancer Treatment
April 26, 2024
Via
Investor Brand Network
TinyGemsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) CEO to Present at LSX World Congress 2024
April 23, 2024
Via
Investor Brand Network
BioMedNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Spotlighted in Upcoming Virtual Investor Lunch Break Event
April 22, 2024
Via
Investor Brand Network
< Previous
1
2
3
4
5
6
7
8
9
10
11
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.